155 related articles for article (PubMed ID: 12642683)
21. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta.
Behrens J; Jerchow BA; Würtele M; Grimm J; Asbrand C; Wirtz R; Kühl M; Wedlich D; Birchmeier W
Science; 1998 Apr; 280(5363):596-9. PubMed ID: 9554852
[TBL] [Abstract][Full Text] [Related]
22. Wnt/beta-catenin signaling pathway as a novel cancer drug target.
Luu HH; Zhang R; Haydon RC; Rayburn E; Kang Q; Si W; Park JK; Wang H; Peng Y; Jiang W; He TC
Curr Cancer Drug Targets; 2004 Dec; 4(8):653-71. PubMed ID: 15578921
[TBL] [Abstract][Full Text] [Related]
23. Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability.
Shimizu Y; Ikeda S; Fujimori M; Kodama S; Nakahara M; Okajima M; Asahara T
Genes Chromosomes Cancer; 2002 Jan; 33(1):73-81. PubMed ID: 11746989
[TBL] [Abstract][Full Text] [Related]
24. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
Jho Eh; Lomvardas S; Costantini F
Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160
[TBL] [Abstract][Full Text] [Related]
25. New steps in the Wnt/beta-catenin signal transduction pathway.
Sakanaka C; Sun TQ; Williams LT
Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
[TBL] [Abstract][Full Text] [Related]
26. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.
Amit S; Hatzubai A; Birman Y; Andersen JS; Ben-Shushan E; Mann M; Ben-Neriah Y; Alkalay I
Genes Dev; 2002 May; 16(9):1066-76. PubMed ID: 12000790
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of a beta-catenin/axin complex suggests a mechanism for the beta-catenin destruction complex.
Xing Y; Clements WK; Kimelman D; Xu W
Genes Dev; 2003 Nov; 17(22):2753-64. PubMed ID: 14600025
[TBL] [Abstract][Full Text] [Related]
28. The subcellular destinations of APC proteins.
Bienz M
Nat Rev Mol Cell Biol; 2002 May; 3(5):328-38. PubMed ID: 11988767
[TBL] [Abstract][Full Text] [Related]
29. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
Sakanaka C; Weiss JB; Williams LT
Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
[TBL] [Abstract][Full Text] [Related]
30. The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway.
Lee E; Salic A; Krüger R; Heinrich R; Kirschner MW
PLoS Biol; 2003 Oct; 1(1):E10. PubMed ID: 14551908
[TBL] [Abstract][Full Text] [Related]
31. Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis.
Kolligs FT; Bommer G; Göke B
Digestion; 2002; 66(3):131-44. PubMed ID: 12481159
[TBL] [Abstract][Full Text] [Related]
32. Biochemical interactions in the wnt pathway.
Seidensticker MJ; Behrens J
Biochim Biophys Acta; 2000 Feb; 1495(2):168-82. PubMed ID: 10656974
[TBL] [Abstract][Full Text] [Related]
33. Identification of a Wnt/beta-catenin signaling pathway in human thyroid cells.
Helmbrecht K; Kispert A; von Wasielewski R; Brabant G
Endocrinology; 2001 Dec; 142(12):5261-6. PubMed ID: 11713224
[TBL] [Abstract][Full Text] [Related]
34. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
[TBL] [Abstract][Full Text] [Related]
35. Wnt/beta-catenin signaling.
Akiyama T
Cytokine Growth Factor Rev; 2000 Dec; 11(4):273-82. PubMed ID: 10959075
[TBL] [Abstract][Full Text] [Related]
36. Modulation of Wnt signaling by Axin and Axil.
Kikuchi A
Cytokine Growth Factor Rev; 1999; 10(3-4):255-65. PubMed ID: 10647780
[TBL] [Abstract][Full Text] [Related]
37. Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein.
Liu J; Stevens J; Rote CA; Yost HJ; Hu Y; Neufeld KL; White RL; Matsunami N
Mol Cell; 2001 May; 7(5):927-36. PubMed ID: 11389840
[TBL] [Abstract][Full Text] [Related]
38. TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling.
Brantjes H; Barker N; van Es J; Clevers H
Biol Chem; 2002 Feb; 383(2):255-61. PubMed ID: 11934263
[TBL] [Abstract][Full Text] [Related]
39. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
[TBL] [Abstract][Full Text] [Related]
40. [Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms].
Friedrich A; Kullmann F
Med Klin (Munich); 2003 Dec; 98(12):776-82. PubMed ID: 14685680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
